Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INBRIJA safely and effectively. See full prescribing information for INBRIJA. INBRIJA ® (levodopa inhalation powder), for oral inhalation use Initial U.S. Approval: 1970
Medication labelWhy this: Advisory · dailymed-prescription
INBRIJA is indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa.
- generic_name
- levodopa
- product_names
- levodopa
- ndc
- 0259-6142, 0259-6142-01, 0259-6142-60, 0259-6142-32, 0259-6142-16
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en